Innovating Works

IDEAS

Financiado
In vivo Directed Evolution As a Service for the development of novel microorgani...
In vivo Directed Evolution As a Service for the development of novel microorganisms leveraging the full potential of White Biotechnology. Today’s exploitation of nature is no longer sustainable. New sustainable industrial processes must urgently be implemented. White Biotechnology, also known as Industrial Biotechnology, has potential to build a greener future by re... Today’s exploitation of nature is no longer sustainable. New sustainable industrial processes must urgently be implemented. White Biotechnology, also known as Industrial Biotechnology, has potential to build a greener future by replacing fossil-based processes for the production of our essential needs. This field uses living microorganisms such as yeast, bacteria and microalgae to generate sustainable industrial products and processes. However, despite significant advancements in genome editing tools, metabolic engineering and data exploitation, these techniques fail in developing microorganisms fulfilling demanding industrial requirements for the production of a wide array of products. For this reason, the potential of White Biotechnology still has to be achieved. Altar is a French Deep Tech founded in 2017 which develops a disruptive platform harnessing the power of natural selection for the development of novel microorganisms fulfilling specific industrial needs. Our innovation induces in vivo directed evolution or adaptative evolution of microorganisms in order to adapt them to the harsh conditions of industrial processes. Altar’s Evolution Platform is based on proprietary technology and culture protocols controlled by novel algorithms. Moreover, its operation is completely automated and digitalized. Altar has built an enthusiastic and skilled team of 8 women and men with combined experience in business, biotechnology, software, engineering, fluidics and microbiology. The EIC Accelerator project aims to finalize the Evolution Platform’s development and commercialize it globally. We gathered 19 letters of interest highlighting interest from various international stakeholders. Our ambition for the next decade is to become a global leader in the development of microorganisms for White Biotechnology and therefore pave the way towards a sustainable and green European future. ver más
31/12/2022
3M€
Duración del proyecto: 24 meses Fecha Inicio: 2020-12-04
Fecha Fin: 2022-12-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2022-12-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 3M€
Líder del proyecto
ALTAR No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5